Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...

Some stores and medical-related facilities have refused service for people inoculated with the replicon COVID-19 vaccine because of unsubstantiated rumors about the dangers of the shots.